| Patents for C12N 5 - Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor (182,629) |
|---|
| 09/21/2005 | CN1670192A In vitro culturing method of oviduct secretory cell of Chinese forest frog |
| 09/21/2005 | CN1670191A In vitro rapid propagating method of Eusteralis stellata and its culture medium |
| 09/21/2005 | CN1670190A Method and device for dry conservation of biological liquid sample |
| 09/21/2005 | CN1219885C Transgenic plants and its prodn. method |
| 09/21/2005 | CN1219882C Method and combination for treating tumors based on ERBB-3 |
| 09/21/2005 | CN1219881C Human protooncogene and protein encoded therein |
| 09/21/2005 | CN1219796C Application of N-end amino acid of interferon-tau polypeptide |
| 09/20/2005 | US6946589 Compositions and methods for altering amino acid content of proteins |
| 09/20/2005 | US6946548 Granulocyte colony stimulating factor ("G-CSF") analog polypeptide compositions, related nucleic acids, expression constructs, host cells, and processes for recombinant production of the present G-CSF analogs. |
| 09/20/2005 | US6946543 Truncated EGF receptor |
| 09/20/2005 | US6946444 Modify the activity of the lipolysis stimulated receptor and can be used to influence the partitioning of dietary lipids between the liver and peripheral tissues; treating obesity-related insulin resistance |
| 09/20/2005 | US6946294 Transgenic plant transformed with a translationally controlled tumor protein (TCTP) gene |
| 09/20/2005 | US6946293 Progenitor cells, methods and uses related thereto |
| 09/20/2005 | US6946291 Mixed cell diagnostic systems |
| 09/20/2005 | US6946275 Human testis specific serine/threonine kinase 1 and 2 |
| 09/20/2005 | US6946272 Transition state analogs |
| 09/20/2005 | US6946264 DNA codes for polypeptides having amino acid sequences used as metalloenzyme inhibitors, for prophylaxis of autoimmune diseases or as wound healing agents |
| 09/20/2005 | US6946262 Comprises membrane protein for treatment and diagnosis of cell proliferative disorders; antitumor/anticarcinogenic agents |
| 09/20/2005 | US6946260 Allergen/inflammatory testing and diagnosis |
| 09/20/2005 | US6946246 Gene expression by culturing cells and contacting with transcription factors comprising single-stranded oligonucleotides or complementary sequences; genetic engineering; gene therapy |
| 09/20/2005 | US6946133 Prostate specific antigen oligo-epitope peptide |
| 09/20/2005 | US6946131 Comprises heparan sulfate proteoglyeans; antiproliferative agents |
| 09/20/2005 | US6946129 Recombinant anti-CD40 antibody and uses thereof |
| 09/20/2005 | US6946127 Block exposure to nerve toxicity |
| 09/20/2005 | CA2261578C Gene expression regulatory dna, expression cassette, expression vector and transgenic plant |
| 09/20/2005 | CA2189882C Papillomavirus vaccines |
| 09/20/2005 | CA2170606C Type i angiotensin ii receptor specific monoclonal antibodies and hybridomas |
| 09/20/2005 | CA2145833C Induction of embryogenesis and generation of doubled plant haploids using microtubule inhibitors |
| 09/20/2005 | CA2106064C Method and apparatus for growing biomass particles |
| 09/18/2005 | CA2501337A1 Chemical dissociation of cell aggregates |
| 09/18/2005 | CA2461241A1 Chemical dissociation of cell aggregates |
| 09/15/2005 | WO2005085447A1 β-FRUCTOFURANOSIDASE MUTANT |
| 09/15/2005 | WO2005085445A1 Recombinant varicella-zoster virus |
| 09/15/2005 | WO2005085444A1 Chithin oligosaccharide elicitor-binding protein |
| 09/15/2005 | WO2005085441A1 Modified promoter |
| 09/15/2005 | WO2005085433A1 Method of regulating o-glycosylation in eucaryotic cell |
| 09/15/2005 | WO2005085429A1 Reverse-flow perfusioin of three-dimensional scaffolds |
| 09/15/2005 | WO2005085428A1 Serum-free suspension culture system for mesenchymal progenitor cells |
| 09/15/2005 | WO2005085427A1 Rat embryonic stem cell |
| 09/15/2005 | WO2005085426A1 Medium for feeder-free differentiation and feeder-free differentiation method from primate embryonic stem cell |
| 09/15/2005 | WO2005085425A1 Method of differentiating mesenchymal stem cells into steroid-producing cells |
| 09/15/2005 | WO2005085424A2 Endothelial progenitor cells and methods of use thereof |
| 09/15/2005 | WO2005085423A1 Oct-4 and gjic expression as markers for adult human stem cells and cancer cell precursors |
| 09/15/2005 | WO2005085422A1 Adult stem cells and uses thereof |
| 09/15/2005 | WO2005085421A2 Treatment of spinal conditions |
| 09/15/2005 | WO2005085420A2 Leukocyte stimulation matrix |
| 09/15/2005 | WO2005085414A1 Patterned board for culturing vascular cells |
| 09/15/2005 | WO2005085413A1 Patterned board for culturing vascular cells |
| 09/15/2005 | WO2005085288A2 Natural igm antibodies and inhibitors thereof |
| 09/15/2005 | WO2005084691A1 Method of proliferating precursor cells |
| 09/15/2005 | WO2005084387A2 Methods and compositions for hybrid cell vaccines for the treatment and prevention of cancer |
| 09/15/2005 | WO2005084276A2 Cell therapy formulation method and composition |
| 09/15/2005 | WO2005084223A2 Methods and compositions for hair growth |
| 09/15/2005 | WO2005084212A2 Cellular tissue culture systems for high-volume processing |
| 09/15/2005 | WO2005084115A2 Ttg3 deficient plants, nucleic acids, polypetides and methods of use thereof |
| 09/15/2005 | WO2005067958A3 Methods and compositions for the inhibition of cathepsins |
| 09/15/2005 | WO2005056569A3 Beta integrin gene and protein |
| 09/15/2005 | WO2005052140A3 Multipotent postnatal stem cells from human periodontal ligament and uses thereof |
| 09/15/2005 | WO2005047491A3 Methods of using g-csf mobilized c-kit+cells in the production of embryoid body-like cell clusters for tissue repair and in the treatment of cardiac myopathy |
| 09/15/2005 | WO2005045396A3 Use of particulate labels in bionalyte detection methods |
| 09/15/2005 | WO2005044999A3 Treatment with immunoregulatory t cells |
| 09/15/2005 | WO2005044982A3 Monomeric recombinant mhc molecules useful for manipulation of antigen-specific t cells |
| 09/15/2005 | WO2005040377A3 High efficiency gene transfer and expression in mammalian cells by a multiple transfection procedure of matrix attachment region sequences |
| 09/15/2005 | WO2005038012A3 Cartilage and bone repair and regeneration using postpartum-derived cells |
| 09/15/2005 | WO2005030040A3 Hematopoietic stem cell identification and isolation |
| 09/15/2005 | WO2005026209A3 Monoclonal antibodies against hmgb1 |
| 09/15/2005 | WO2005012496A3 Novel nucleic acids from sesame plants |
| 09/15/2005 | WO2005010151A3 Antibodies directed to the deletion mutants of epidermal growth factor receptor and uses thereof |
| 09/15/2005 | WO2005003720A3 Method of detecting the cystic fibrosis transmembrane conductance regulator (cftr) at cell exterior |
| 09/15/2005 | WO2005002511A3 Recombinant antibodies and compositions and methods for making and using the same |
| 09/15/2005 | WO2004110372A3 Room temperature storage of organs |
| 09/15/2005 | WO2004084823A3 Antibodies against t cell immunoglobulin domain and mucin domain 1 (tim-1) antigen and uses thereof |
| 09/15/2005 | WO2004084711A3 Methods of detecting neurological disorders |
| 09/15/2005 | WO2004065580A3 Mesecnhymal stem cells as a vehicle for ion channel transfer in syncytial structures |
| 09/15/2005 | WO2003000844A3 Protein modification and maintenance molecules |
| 09/15/2005 | US20050204431 Use of specific myb genes for the production of transgenic plants tolerant to biotic and abiotic stresses |
| 09/15/2005 | US20050204429 polynucleotide constructs, expression cassettes, vectors, or inserts into the chromosome or as an exogenous element, to modulate in vivo and in vitro transcription of polynucleotides; host cells, plants and seeds |
| 09/15/2005 | US20050204424 for transgenic plants |
| 09/15/2005 | US20050204422 Using vector transformation to express antisense sequences which suppress phytoene desaturase activity and enhance phytoene concentration in plant |
| 09/15/2005 | US20050204421 Insecticidal protein; increasing resistance of plants to insects |
| 09/15/2005 | US20050204417 Expression vector comprising nucleotide sequences coding novel transferase for generation of plants with increased metabolic flux toward monoterpenes; improving production of essential oils in plants |
| 09/15/2005 | US20050204416 Plant cells having receptor polypeptides |
| 09/15/2005 | US20050204412 Artery- and vein-specific proteins and uses therefor |
| 09/15/2005 | US20050204406 Expression vector comprising nucleotide sequences coding blood coagulation factor for use as heterologous gene expression tool; treating blood disorders; bioreactor for producing secreted proteins |
| 09/15/2005 | US20050203636 Decellularized grafts from umbilical cord vessels and process for preparing and using same |
| 09/15/2005 | US20050203282 For screening of agonists and antagonists of receptor which may have advantageous pharmaceutical or diagnostical properties; for identification of patients who may present genetic disorders induced by inactive receptor |
| 09/15/2005 | US20050203033 Identification and characterization of an anthocyanin mutant (ant1) in tomato |
| 09/15/2005 | US20050203022 Type II TGF-beta receptor/immunoglobulin constant region fusion proteins |
| 09/15/2005 | US20050203012 Human parathyroid hormone modifications, preparation and use |
| 09/15/2005 | US20050202560 Simian immunodeficiency retroviral vector for use efficient tool in heterologous gene transfer; improved exogenous gene expression; gene therapy |
| 09/15/2005 | US20050202558 Methods for purification of cells based on product secretion |
| 09/15/2005 | US20050202557 Micromachined bilayer unit of engineered tissues |
| 09/15/2005 | US20050202553 Animal cells and processes for the replication of influenza viruses |
| 09/15/2005 | US20050202547 Allows the above microorganism to use cyclododecanol and cyclododecanone (12-membered ring compounds) as sole carbon source for growth and energy |
| 09/15/2005 | US20050202529 Humanised antibodies |
| 09/15/2005 | US20050202527 Fusion polypeptide comprising fibrinopeptide A, serine protease and thrombin-cleavable sequences for use in identifying modulators for prevention and treatment of thrombotic disorders; anticoagulants |
| 09/15/2005 | US20050202526 Secreted and transmembrane polypeptides and nucleic acids encoding the same |
| 09/15/2005 | US20050202520 Has a histidine tag and where the subdomain of the IMPDH polypeptide is modified so that the rate stability of the modified polypeptide is maintained relative to the wild-type IMPDH polypeptide |
| 09/15/2005 | US20050202519 Mutated abl kinase domains |
| 09/15/2005 | US20050202517 Monoclonal antibodies against human apoptosis inhibitory protein NAIP and method for assaying the NAIP |